Walleye Capital
TNGX icon

Walleye Capital’s Tango Therapeutics TNGX Stock Holding History

Walleye Capital’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.01M Buy
+192,270
New +$4.75M 0.02% 723
2025
Q2 		– Sell
-211,797
Closed -$290K – 5040
2025
Q1 		$290K Sell
211,797
-75,255
-26% -$185K ﹤0.01% 2980
2024
Q4 		$887K Buy
287,052
+144,476
+101% +$671K ﹤0.01% 2484
2024
Q3 		$1.1M Buy
+142,576
New +$1.36M ﹤0.01% 2563
2024
Q2 		– Sell
-13,172
Closed -$105K – 6014
2024
Q1 		$105K Sell
13,172
-8,990
-41% -$96.4K ﹤0.01% 4373
2023
Q4 		$219K Buy
+22,162
New +$192K ﹤0.01% 3622
2023
Q1 		– Sell
-289,867
Closed -$2.1M – 4368
2022
Q4 		$2.1M Sell
289,867
-114,780
-28% -$807K 0.04% 554
2022
Q3 		$1.47M Buy
+404,647
New +$1.73M 0.03% 720
2021
Q4 		– Sell
-41,415
Closed -$535K – 2320
2021
Q3 		$535K Buy
+41,415
New +$496K 0.02% 761

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Walleye Capital's TNGX Position: Q2 2026 in Review

Walleye Capital opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 192,270 shares worth $6.01M. The stake represents 0.02% of the portfolio and ranks #723 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TNGX as recently as Q1 2025.

Walleye Capital first reported a position in TNGX in Q3 2021 and has held it in 9 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Walleye Capital held 192,270 shares of Tango Therapeutics worth $6.01M as of Q2 2026.
  • Tango Therapeutics was a new Walleye Capital position in Q2 2026.
  • Tango Therapeutics made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #723 holding.
  • Walleye Capital first reported a position in Tango Therapeutics in Q3 2021 and has held it in 9 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.